Parallel Advisors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.2K Buy
561
+300
+115% +$28.2K ﹤0.01% 2111
2026
Q1
$23.2K Buy
261
+247
+1,764% +$25.4K ﹤0.01% 2415
2025
Q4
$1.34K Hold
14
﹤0.01% 3229
2025
Q3
$1.38K Sell
14
-1
-7% -$107 ﹤0.01% 3139
2025
Q2
$1.6K Buy
15
+12
+400% +$1.21K ﹤0.01% 3095
2025
Q1
$305 Sell
3
-252
-99% -$28.2K ﹤0.01% 3322
2024
Q4
$29.1K Buy
255
+3
+1% +$342 ﹤0.01% 1958
2024
Q3
$29.9K Buy
252
+80
+47% +$7.36K ﹤0.01% 1866
2024
Q2
$13.8K Hold
172
﹤0.01% 2178
2024
Q1
$15.9K Hold
172
﹤0.01% 2102
2023
Q4
$18.2K Sell
172
-8
-4% -$806 ﹤0.01% 2000
2023
Q3
$19.6K Buy
180
+31
+21% +$3.43K ﹤0.01% 1857
2023
Q2
$16.1K Hold
149
﹤0.01% 1949
2023
Q1
$18.6K Sell
149
-48
-24% -$6.59K ﹤0.01% 1870
2022
Q4
$29.6K Sell
197
-155
-44% -$23.9K ﹤0.01% 1529
2022
Q3
$47K Hold
352
﹤0.01% 1292
2022
Q2
$52K Buy
352
+30
+9% +$4.58K ﹤0.01% 1227
2022
Q1
$56K Sell
322
-31
-9% -$5.21K ﹤0.01% 1236
2021
Q4
$91K Buy
353
+38
+12% +$10.4K ﹤0.01% 1053
2021
Q3
$86K Sell
315
-10
-3% -$3.18K ﹤0.01% 1042
2021
Q2
$73K Hold
325
﹤0.01% 1057
2021
Q1
$35K Buy
325
+275
+550% +$29.2K ﹤0.01% 1334
2020
Q4
$4K Sell
50
-25
-33% -$2.45K ﹤0.01% 2075
2020
Q3
$5K Hold
75
﹤0.01% 1996
2020
Q2
$5K Buy
+75
New +$3.75K ﹤0.01% 1939

Other funds holding BNTX

Parallel Advisors's BNTX Position: Q2 2026 in Review

Parallel Advisors increased its BioNTech (BNTX) stake by 115% in Q2 2026, buying an estimated $28.2K and bringing the position to 561 shares worth $52.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2111.

Parallel Advisors first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $91K in Q4 2021. 112 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Parallel Advisors held 561 shares of BioNTech worth $52.2K as of Q2 2026.
  • Parallel Advisors bought 300 BioNTech shares in Q2 2026, an estimated $28.2K.
  • BioNTech made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2111 holding.
  • Parallel Advisors first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • Parallel Advisors's BioNTech position peaked at $91K in Q4 2021.
  • 112 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.